months), treatment complexity (i.e., number of differentdrugs prescrib terjemahan - months), treatment complexity (i.e., number of differentdrugs prescrib Bahasa Indonesia Bagaimana mengatakan

months), treatment complexity (i.e.

months), treatment complexity (i.e., number of different
drugs prescribed), and diagnosis group. No differences were
obtained in the MMAS-8 total score as a function of gender
[F (2, 948) = 2.07) or adherence group (i.e., high, medium,
low): 2 (2) = 3.99)]. However, a significant correlation was
found between the scale and age (rxy = .19; p = .000): adherence
increased with patient age. No significant correlations
were found as a function of educational level (rxy = .04),
treatment complexity (rxy = -.01), or treatment duration
(rxy = .05). Yet, when the statistical analysis was conducted
considering the level of adherence, we found significant
differences between the three groups as a function of
treatment duration (F (2, 948) = 4.75, p = .003; 2 = .01).
Bonferroni tests revealed that patients with high adherence
(M = 118.65 months, SD = 112.16) and patients with medium
adherence (M = 121.17, SD = 120.72) underwent longer treatments
than those with low adherence (M 95.54, SD = 94.09).
However, the high standard deviation indicates that these
data should be taken with caution, as they show an irregular
distribution of scores.
As regards diagnosis groups, an ANOVA revealed that
the MMAS-8 was able to differentiate between the five
major groups of disorders (i.e., schizophrenia, bipolar
disorder, depression, anxiety, and personality disorders):
F (4, 932) = 6.35; p = .000; 2 = .027). According to the
Bonferroni test, patients with bipolar disorder exhibited
the highest adherence (M = 6.8, SD = 1.42). This score was
significant higher than that of patients with personality disorders
(M = 5.35, SD = 1.58) and anxiety disorders (M = 6.13,
SD = 1.7). In addition, patients with schizophrenia (M = 6.41,
SD = 1.42) and patients with depressive disorders (M = 6.36,
0/5000
Dari: -
Ke: -
Hasil (Bahasa Indonesia) 1: [Salinan]
Disalin!
months), treatment complexity (i.e., number of differentdrugs prescribed), and diagnosis group. No differences wereobtained in the MMAS-8 total score as a function of gender[F (2, 948) = 2.07) or adherence group (i.e., high, medium,low): 2 (2) = 3.99)]. However, a significant correlation wasfound between the scale and age (rxy = .19; p = .000): adherenceincreased with patient age. No significant correlationswere found as a function of educational level (rxy = .04),treatment complexity (rxy = -.01), or treatment duration(rxy = .05). Yet, when the statistical analysis was conductedconsidering the level of adherence, we found significantdifferences between the three groups as a function oftreatment duration (F (2, 948) = 4.75, p = .003; 2 = .01).Bonferroni tests revealed that patients with high adherence(M = 118.65 months, SD = 112.16) and patients with mediumadherence (M = 121.17, SD = 120.72) underwent longer treatmentsthan those with low adherence (M 95.54, SD = 94.09).However, the high standard deviation indicates that thesedata should be taken with caution, as they show an irregulardistribution of scores.As regards diagnosis groups, an ANOVA revealed thatthe MMAS-8 was able to differentiate between the fivemajor groups of disorders (i.e., schizophrenia, bipolardisorder, depression, anxiety, and personality disorders):F (4, 932) = 6.35; p = .000; 2 = .027). According to theBonferroni test, patients with bipolar disorder exhibitedthe highest adherence (M = 6.8, SD = 1.42). This score wassignificant higher than that of patients with personality disorders(M = 5.35, SD = 1.58) and anxiety disorders (M = 6.13,SD = 1.7). In addition, patients with schizophrenia (M = 6.41,SD = 1.42) and patients with depressive disorders (M = 6.36,
Sedang diterjemahkan, harap tunggu..
Hasil (Bahasa Indonesia) 2:[Salinan]
Disalin!
bulan), kompleksitas pengobatan (yaitu, jumlah yang berbeda
obat yang diresepkan), dan kelompok diagnosis. Tidak ada perbedaan yang
diperoleh di MMAS-8 skor total sebagai fungsi gender
[F (2, 948) = 2,07) atau kelompok kepatuhan (yaitu, tinggi, sedang,
rendah): 2 (2) = 3,99)]. Namun, korelasi yang signifikan
ditemukan antara skala dan usia (rxy = 0,19; p = 0,000): kepatuhan
meningkat dengan usia pasien. Tidak ada korelasi yang signifikan
ditemukan sebagai fungsi dari tingkat pendidikan (rxy = 0,04),
kompleksitas pengobatan (rxy = -.01), atau durasi pengobatan
(rxy = 0,05). Namun, ketika analisis statistik dilakukan
mengingat tingkat kepatuhan, kami menemukan signifikan
perbedaan antara tiga kelompok sebagai fungsi dari
durasi pengobatan (F (2, 948) = 4.75, p = 0,003;? 2 = 0,01).
tes Bonferroni menunjukkan bahwa pasien dengan kepatuhan tinggi
(M = 118,65 bulan, SD = 112,16) dan pasien dengan media
kepatuhan (M = 121,17, SD = 120,72) menjalani lagi perawatan
dibandingkan dengan kepatuhan yang rendah (M 95,54, SD = 94,09).
Namun , standar deviasi yang tinggi menunjukkan bahwa
data yang harus diambil dengan hati-hati, karena mereka menunjukkan tidak teratur
distribusi skor.
Mengenai kelompok diagnosis, sebuah ANOVA mengungkapkan bahwa
para MMAS-8 mampu membedakan antara lima
kelompok utama dari gangguan (yaitu , skizofrenia, bipolar
gangguan gangguan, depresi, kecemasan, dan kepribadian):
F (4, 932) = 6,35; p = 0,000; ? 2 = 0,027). Menurut
uji Bonferroni, pasien dengan gangguan bipolar dipamerkan
kepatuhan tertinggi (M = 6.8, SD = 1,42). Skor ini adalah
lebih tinggi signifikan daripada pasien dengan gangguan kepribadian
(M = 5.35, SD = 1.58) dan gangguan kecemasan (M = 6.13,
SD = 1,7). Selain itu, pasien dengan skizofrenia (M = 6.41,
SD = 1,42) dan pasien dengan gangguan depresi (M = 6.36,
Sedang diterjemahkan, harap tunggu..
 
Bahasa lainnya
Dukungan alat penerjemahan: Afrikans, Albania, Amhara, Arab, Armenia, Azerbaijan, Bahasa Indonesia, Basque, Belanda, Belarussia, Bengali, Bosnia, Bulgaria, Burma, Cebuano, Ceko, Chichewa, China, Cina Tradisional, Denmark, Deteksi bahasa, Esperanto, Estonia, Farsi, Finlandia, Frisia, Gaelig, Gaelik Skotlandia, Galisia, Georgia, Gujarati, Hausa, Hawaii, Hindi, Hmong, Ibrani, Igbo, Inggris, Islan, Italia, Jawa, Jepang, Jerman, Kannada, Katala, Kazak, Khmer, Kinyarwanda, Kirghiz, Klingon, Korea, Korsika, Kreol Haiti, Kroat, Kurdi, Laos, Latin, Latvia, Lituania, Luksemburg, Magyar, Makedonia, Malagasi, Malayalam, Malta, Maori, Marathi, Melayu, Mongol, Nepal, Norsk, Odia (Oriya), Pashto, Polandia, Portugis, Prancis, Punjabi, Rumania, Rusia, Samoa, Serb, Sesotho, Shona, Sindhi, Sinhala, Slovakia, Slovenia, Somali, Spanyol, Sunda, Swahili, Swensk, Tagalog, Tajik, Tamil, Tatar, Telugu, Thai, Turki, Turkmen, Ukraina, Urdu, Uyghur, Uzbek, Vietnam, Wales, Xhosa, Yiddi, Yoruba, Yunani, Zulu, Bahasa terjemahan.

Copyright ©2024 I Love Translation. All reserved.

E-mail: